Alrashidi Anwar R, Shaheen Esraa, Abualola Amal, Alharkan Alanoud A, Aljuaid Abdulaziz, Alshareef Khalid M, Ghaddaf Abdullah A, Alamri Samer, Samarkandy Sahal J
Department of Dermatology, King Fahad Medical City, Riyadh.
College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah; King Abdullah International Medical Research Center, Jeddah.
Dermatol Reports. 2025 May 23;17(2). doi: 10.4081/dr.2024.10121. Epub 2024 Oct 25.
Several treatment modalities for palmoplantar warts (PPW) have been introduced, but none have been proven to be significantly effective in all patients. The study aims to assess the efficacy and safety of cryotherapy compared to other modalities for PPW. Searches were conducted in Medline, Embase, Scopus, and CENTRAL databases, along with additional reference and citation tracking from included studies. Randomized controlled trials (RCTs) comparing various treatments for PPW were included. Two independent pairs extracted the data from the included studies. Outcomes assessed included cure rates, pain scores, recurrence rates, and adverse events. A network meta-analysis using Netmeta in R software was employed, with treatments ranked by p-scores. A total of 27 RCTs that enrolled 2539 participants were deemed eligible. As per p-scores, needling yielded the highest odds for the cure rate (p=1.00), followed by intralesional injection of the measles, mumps, and rubella (MMR) vaccine (p=0.90). For the pain score, 76% topical monochloroacetic acid (p=0.13) showed the lowest mean pain score, while cryotherapy yielded the highest score (p=0.90). Furthermore, cryotherapy showed the highest odds for recurrence rate (p=0.75), followed by intralesional injection of Candida antigen (p=0.61). Regarding adverse events, 0.05% intralesional bleomycin had the highest rate (p=0.93), followed by cryotherapy (p=0.61).
已经介绍了几种治疗掌跖疣(PPW)的方法,但没有一种被证明对所有患者都有显著疗效。本研究旨在评估冷冻疗法与其他治疗PPW的方法相比的疗效和安全性。在Medline、Embase、Scopus和CENTRAL数据库中进行了检索,并对纳入研究的参考文献和引用进行了额外追踪。纳入了比较PPW各种治疗方法的随机对照试验(RCT)。两组独立人员从纳入研究中提取数据。评估的结果包括治愈率、疼痛评分、复发率和不良事件。使用R软件中的Netmeta进行网络荟萃分析,根据p值对治疗方法进行排序。共有27项RCT纳入了2539名参与者,被认为符合条件。根据p值,针刺疗法治愈率的优势比最高(p=1.00),其次是病灶内注射麻疹、腮腺炎和风疹(MMR)疫苗(p=0.90)。对于疼痛评分,76%的局部使用单氯乙酸(p=0.13)显示平均疼痛评分最低,而冷冻疗法的评分最高(p=0.90)。此外,冷冻疗法复发率的优势比最高(p=0.75),其次是病灶内注射白色念珠菌抗原(p=0.61)。关于不良事件,0.05%的病灶内注射博来霉素发生率最高(p=0.93),其次是冷冻疗法(p=0.61)。
Cochrane Database Syst Rev. 2012-9-12
Cochrane Database Syst Rev. 2003
Cochrane Database Syst Rev. 2017-12-22
Cochrane Database Syst Rev. 2021-4-19
Cochrane Database Syst Rev. 2001
Cochrane Database Syst Rev. 2020-1-9
Cochrane Database Syst Rev. 2025-6-16
Cochrane Database Syst Rev. 2006-7-19
Health Technol Assess. 2024-10
J Evid Based Med. 2022-9
Dermatol Ther. 2022-6
Expert Rev Mol Diagn. 2021-12
Dermatol Ther. 2021-1
Dermatol Online J. 2020-3-15
Dermatol Ther. 2020-5